Backers claim the tests can predict a child’s risk of autism using a strand of hair or a mother’s blood, but critics say they ...
Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback